Advanced search
Publication Cover
Breast Cancer: Targets and Therapy Volume 7, 2015 - Issue
Submit an article Journal homepage
149
Views
6
CrossRef citations to date
0
Altmetric
Review

Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer

Pooja Advani1 Division of Hematology and Oncology, Jacksonville, FL, USA
,
Lauren Cornell2 Department of Internal Medicine, Mayo Clinic, Jacksonville, FL, USA
,
Saranya Chumsri1 Division of Hematology and Oncology, Jacksonville, FL, USA
&
Alvaro Moreno-Aspitia1 Division of Hematology and Oncology, Jacksonville, FL, USACorrespondence[email protected]
Pages 321-335 | Published online: 22 Sep 2015

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Qin Wang, Yinan Zhong, Wenting Liu, Zemin Wang, Liqin Gu, Xuejiao Li, Jiqing Zheng, Huan Du, Zhiyuan Zhong & Fang Xie. (2019) Enhanced chemotherapeutic efficacy of the low-dose doxorubicin in breast cancer via nanoparticle delivery system crosslinked hyaluronic acid. Drug Delivery 26:1, pages 12-22.
Read now

Articles from other publishers (5)

Huaying Xie, Tingting Yan, Xinxin Lu, Yueyao Du, Shuguang Xu, Yu Kong, Liangjie Yu, Jian Sun, Liheng Zhou & Jun Ma. (2022) GLDC mitigated by miR-30e regulates cell proliferation and tumor immune infiltration in TNBC. Frontiers in Immunology 13.
Crossref
Eriko Tokunaga, Norikazu Masuda, Naohito Yamamoto, Hiroji Iwata, Hiroko Bando, Tomoyuki Aruga, Shoichiro Ohtani, Tomomi Fujisawa, Toshimi Takano, Kenichi Inoue, Nobuyasu Suganuma, Masahiro Takada, Kenjiro Aogi, Kenichi Sakurai, Hideo Shigematsu, Katsumasa Kuroi, Hironori Haga, Shinji Ohno, Satoshi Morita & Masakazu Toi. (2021) Long-Term Outcomes of a Randomized Study of Neoadjuvant Induction Dual HER2 Blockade with Trastuzumab and Lapatinib Followed by Weekly Paclitaxel Plus Dual HER2 Blockade for HER2-Positive Primary Breast Cancer (Neo-Lath Study). Cancers 13:16, pages 4008.
Crossref
Karissa Britten & Nicholas P McAndrew. (2021) Pathologic Complete Response as a Surrogate Endpoint in Breast Cancer. Oncology & Haematology 17:1, pages 12.
Crossref
Lucian Pop, Ioan Dumitru Suciu, Olivia Ionescu, Paris Ionescu & Oana Daniela Toader. (2019) The Dual Blockade in the Neoadjuvant Setting of HER-2 Positive Early-Stage Breast Cancer. Journal of Medicine and Life 12:4, pages 329-331.
Crossref
Kyung-Hee Chun, Jong Hoon Park & Siting Fan. 2017. Translational Research in Breast Cancer. Translational Research in Breast Cancer 59 104 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.